As of last week, parents will have one more option to help their children battle Juvenile Idiopathic Arthriti (JIA). The FDA has approved Orencia (abatacept) for the treatment of moderate to severe polyarticular JIA. This may be a very welcome treatment option for children who have not responded to TNF-inhibitors or other drugs already approved... Read more
I read a recent article by Julie Appleby in USA Today discussing whether the increase in drug advertising benefits patients or costs the country more money in health care spending. According to the article, drug companies spent about $4.8 billion on advertising in 2006, almost double what they spent in 2002. The article stated that ads for... Read more
Nonsteroidal anti inflammatory drugs (NSAIDs) are commonly used to treat the pain and swelling of arthritis and other musculoskeletal conditions. NSAIDs come in prescription form (e.g. Celebrex, Mobic) and over the counter (e.g. aspirin, ibuprofen). Studies have shown that about 30% of people with some form of arthritis use over-the-counter NSAIDs... Read more
A study published in the December issue of Arthritis Care and Research found that RA patient are nearly twice as likely to develop herpes zoster (also known as shingles) as people without RA. This large, dual country population-based study also found that people with RA who take DMARDs or oral corticosteroids seem to be at higher risk than people... Read more